UNICA IRIS Institutional Research Information System

FULGHESU, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 87.971
NA - Nord America 6.377
AS - Asia 2.314
SA - Sud America 361
AF - Africa 38
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 7
Totale 97.095
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 86.195
US - Stati Uniti d'America 6.314
SG - Singapore 1.016
CN - Cina 952
UA - Ucraina 555
SE - Svezia 466
BR - Brasile 308
GB - Regno Unito 195
DE - Germania 174
FI - Finlandia 148
VN - Vietnam 104
FR - Francia 62
IE - Irlanda 55
KR - Corea 55
IN - India 44
RU - Federazione Russa 40
CA - Canada 35
PK - Pakistan 29
AU - Australia 24
AR - Argentina 23
MX - Messico 21
BE - Belgio 15
NL - Olanda 15
TR - Turchia 13
BD - Bangladesh 12
HK - Hong Kong 12
ID - Indonesia 11
PL - Polonia 10
EG - Egitto 9
ES - Italia 9
ZA - Sudafrica 8
EU - Europa 7
IR - Iran 7
LT - Lituania 7
NG - Nigeria 7
PH - Filippine 7
UZ - Uzbekistan 7
CO - Colombia 6
EC - Ecuador 6
IQ - Iraq 6
JP - Giappone 6
PE - Perù 6
RO - Romania 6
JO - Giordania 5
SA - Arabia Saudita 5
KE - Kenya 4
PY - Paraguay 4
AT - Austria 3
CH - Svizzera 3
CL - Cile 3
TN - Tunisia 3
VE - Venezuela 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
LK - Sri Lanka 2
LY - Libia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
UY - Uruguay 1
YE - Yemen 1
Totale 97.095
Salva come PNG Salva come JPEG
Città #
Cagliari 83.260
Uta 2.537
Fairfield 672
Ashburn 532
Singapore 492
Woodbridge 482
Chandler 433
Houston 411
Boardman 393
Dallas 329
Wilmington 303
Nyköping 297
Jacksonville 293
Ann Arbor 287
Seattle 279
Cambridge 245
Beijing 165
Nanjing 128
Boston 111
Santa Clara 108
Dearborn 104
Menlo Park 104
Hefei 100
Los Angeles 99
Buffalo 92
Helsinki 77
Seoul 54
The Dalles 50
Shanghai 49
San Diego 44
Milan 37
Ho Chi Minh City 36
Redwood City 36
Shenyang 34
Hebei 33
Changsha 29
Nanchang 27
Jiaxing 26
Orange 24
Hanoi 23
São Paulo 23
Tianjin 23
Guangzhou 20
Toronto 20
Chicago 19
New York 17
Norwalk 16
Brussels 15
Frankfurt am Main 14
Verona 14
Council Bluffs 13
London 13
Stockholm 13
Munich 12
Rome 12
San Francisco 12
Washington 12
Pune 11
Zhengzhou 11
Belo Horizonte 10
Brooklyn 10
Jinan 10
Warsaw 10
Florence 9
Hong Kong 9
Saint Petersburg 9
Curitiba 8
Kunming 8
Lahore 8
Phoenix 8
Redondo Beach 8
Sassari 8
Düsseldorf 7
Ankara 6
Atlanta 6
Dublin 6
Genoa 6
Goiânia 6
Johannesburg 6
Lauterbourg 6
Mexico City 6
Mountain View 6
Poplar 6
Tashkent 6
Wuhan 6
Auburn Hills 5
Biên Hòa 5
Bologna 5
Columbus 5
Da Nang 5
Fortaleza 5
Gonnosfanadiga 5
Kilburn 5
Palermo 5
Porto Alegre 5
Portsmouth 5
Redmond 5
Rio de Janeiro 5
Siauliai 5
Taizhou 5
Totale 93.394
Salva come PNG Salva come JPEG
Nome #
IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance 2.798
Is there a dose-response relationship of metformin treatment in patients with polycistic ovary syndrome? Results from a multicentric study 2.557
Stained amniotic fluid: what's new? 2.415
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 2.297
Il-6 serum levels and production in PCOS adolescents is related to insulin resistance 2.292
Very low dose of flutamide in the treatment of hyperandrogenism 2.282
Inflammatory response to lypopolysaccharide in mononuclear cells from polycystic ovary syndrome insulin resistant adolescent 2.267
Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome 2.026
Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome 1.900
Ultrasound diagnosis of polycystic ovarian syndrome: current guidelines, criticism and possible update 1.856
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 1.764
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 1.682
Ovulation induction in young girls with menometrorragia: a safe and effective treatment 1.645
Obesity related lipid profileand altered insulin incretion in adolescent with policystic ovary syndrome 1.641
L'ovaio nella Sindrome dell'ovaio policistico 1.613
Pathogenesis 1.373
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.339
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.260
Dismenorrea: dalle limitazioni alla quotidianità ai dolori pelvici 1.257
Criteri diagnostici di PCOS: recenti evoluzioni 1.226
Ecografia in ginecologia dell'infanzia e dell'adolescenza. Testo atlante 1.226
Diagnosis of metabolic disorders in women with polycystic ovary syndrome 1.212
Obesity realated lipid profile and altered insulin incretion in adolescent with PCOS 1.191
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome 1.165
Metformin effect on ovarian ultrasoundappearance and steroidogenetic functionin normal weightnormoinsulinemic women with polycystic ovary sindrome:a randomized double blind placebo-controlledclinical trial 1.146
Influenza dei parametri antropometrici sulla risposta alla Metformina in pazienti con PCOS. 1.084
null 1.083
78) PITUITARY – OVARIAN RESPONSE TO GONADOTROPIN- RELESING HORMONE AGONIST TEST IN ANOVULATORY PATIENTS WITH POLYCYSTIC OVARY STROMA. PREDICTIVE ROLE OF OVARIAN STROMA 1.062
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS) 994
Differenze regionali nella risposta alla Metformina in pazienti con PCOS 982
133. Metformin effect in PCOS patients is not dose dependent 966
Diagnosi dei problemi metabolici nelle donne con PCOS 948
Endocrine and metabolic aspects in obese and lean young PCOS 940
Ultrasound in PCOS: revisiting Rotterdam criteria 935
The quantitative insulin sensitivity check index (QUICKY) is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 893
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 851
LA DIAGNOSI ECOGRAFICA DELLA PCOS 839
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. 831
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study. 826
Ovarian stromal hypertropy and insulin abnormalities in PCOS 806
82. Pituitary-ovarian response to gonadotrpin-releasing hormone-agonist test in anovulatory patients with polycystic ovary sindrome. Predictive role of ovarian stroma 803
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. 771
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome. 762
Ovarian stroma in PCOS: relationship with circulating androgens 758
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration. 757
Iperinsulinemia in adolescenti affette da PCOS 743
null 740
null 735
Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 728
Good practice in pediatric and adolescent gynecology 727
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. 720
Confronto tra autovalutazione e valutazione clinica dell’irsutismo e dell’immagine corporea in adolescenza 716
Espressione genica e livelli circolanti di resistita in giovani pazienti affette da PCOS 705
CHANGES IN LUTEINIZING HORMONE AND INSULIN SECRETION IN POLYCYSTIC OVARIAN SYNDROME 705
Assetto lipidico in adolescenti affette da PCOS 699
Ovarian stromal hypertrophy and insulin abnormalities in young PCOS 678
EFFECT OF OPIOID BLOCKADE ON INSULIN AD GROWTH HORMONE (GH) SECRETION IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME: THE HETEROGENEITY OF IMPAIRED GH SECRETION IS RELATED TO BOTH OBESITY AND HYPERINSULINISM 659
N-ACETYL-CYSTEINE TREATMENT IMPROVES THE INSULIN SENSITIVITY IN PCOS 654
Relationship between genetic and metabolic abnormalities in PCOS 637
PRECONCEPTIONAL AND GESTATIONAL EVALUATION OF INSULIN SECRETION IN PATIENTS WITH COLYCYSTIC OVARY SYNDROME 635
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 627
Knowledge of the microbiota: personal experience from 324 questionnaires administered to mother and mothers-to-be. 582
null 565
THE IMPACT OF INSULIN SECRETION ON THE OVARIAN RESPONSE TO EXOGENOUS GONADOTROPINS IN POLYCYSTIC OVARY SYNDROME 564
ACUTE INSULIN RESPONSE TO INTRAVENOUS GLUCAGONE IN POLYCYSTIC OVARY SYNDROME 542
EVIDENCE OF A DISTINCT DERANGEMENT OF OPIOID TONE IN HYPERINSULINEMIC PATIENTS WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH INSULIN AND LUTEINIZING HORMONE 540
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside. A Systematic Literature Review 532
CORTICOTROPIN RELEASING HORMONE INDUCES AN EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN POLYCYSTIC OVARY SYNDROME 529
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome 519
An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility 502
EFFECT OF OPIOID BLOCKADE ON INSULIN METABOLISM IN POLYCYSYIC OVARIAN DISEASE 500
Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study 500
ENDOCRINO-METABOLIC FEATURES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME DURING PREGNANCY 500
SOMATOSTATIN TREATMENT REDUCES THE EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIN HORMONE AND CORTISOL TO CORTICOTROPIN -RELEASING HORMONE IN POLYCYSTIC OVARY SYNDROME 497
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 472
Hirsutism and hyperandrogenism associated with hyperreactio luteinalis in a singleton pregnancy: a case report. 471
EVIDENCE OF A DISTURBANCE OF THE HYPOTALAMIC PITUITARY ADRENAL AXIS IN POLYCYSTIC OVARY SYNDROME EFFECT OF NALOXONE 457
GROWTH HORMONE ENHANCES ESTRADIOL PRODUCTION FSH INDUCED IN THE EARLY STAGE OF THE FOLLICULAR MATURATION 431
TEMPOROLIMBIC EPILEPSY AND POLYCYSTIC OVARY SYNDROME 431
Which treatment options should be used in adolescents with polycystic ovary syndrome? 429
EFFECTIVENESS OF A SOMATOSTATIN ANALOGUE IN LOWERING LH AND INSULIN SECRETION IN HYPERINSULINEMIC WOMEN WITH POLYCYSTIC OVARIAN DISEASE 425
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 420
Get a clear view before starting: Endometrial preparation with hormones 408
Polycystic Ovarian Morphology in Normocyclic Non-hyperandrogenic Adolescents 399
Prevalenza dei markers di autoimmunità nelle pazienti affette da preeclampsia 397
null 395
Adolescence and hyperinsulinemia: it is always the first step towards PCOS? 394
Correlation of ovarian stromal hypertrophy to hyperandrogenism and insulin resistance in young women with PCOS 393
Influenza del peso sulla risposta al test all’analogo del GnRH (GnRHa) in PCOS 393
HETEROGENEITY IN ß- CELL ACTIVITY, HEPATIC INSULIN CLEARANCE AND PERIPHERAL INSULIN SENSITIVITY IN WOMEN WITH POLYCYCSTIC OVARY SYNDROME 387
Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries 382
Studio osservazionale sulle irregolarità mestruali in adolescenza 375
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. 335
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. 331
Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease. 322
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist. 314
Effect of maternal carbohydrate metabolism on fetal growth. 314
Comment on "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome". 313
Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum. 310
Progesterone and LH variations after LH-RH administration in the luteal phase of the menstrual cycle. 307
Totale 89.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.947 0 0 0 0 0 2.334 2.079 1.280 320 745 736 453
2021/20225.423 614 410 311 304 515 287 509 400 308 505 610 650
2022/20239.880 708 1.033 1.217 923 568 769 462 914 817 819 1.217 433
2023/202412.200 404 338 372 574 1.147 2.068 2.134 633 1.185 884 1.364 1.097
2024/202514.395 1.871 3.195 2.302 2.372 1.262 1.169 1.063 94 252 269 239 307
2025/20262.393 344 405 772 365 418 89 0 0 0 0 0 0
Totale 97.422